Viloxazine: a review of its pharmacological properties and therapeutic efficacy in depressive illness.
D000818:Animals; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy*; D004311:Double-Blind Method; D004341:Drug Evaluation; D004347:Drug Interactions; D006207:Half-Life; D006801:Humans; D007928:Lethal Dose 50; D009025:Morpholines / Q000627:therapeutic use*; D014745:Viloxazine / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*
D000929:Antidepressive Agents, Tricyclic; D009025:Morpholines; D014745:Viloxazine